Study Type
Observational - Registry
REMEDY was the first large, multi-country registry and cohort study of thousands of people with rheumatic heart disease (RHD) across much of Africa, the Middle East, and East Asia.
The objective of the REMEDY study was to:
Another Co-Principal Investigator on the REMEDY study was Ganesan Karthikeyan, Professor, Cardiology, All India Institute of Medical Sciences.
Observational - Registry
Registry
14
25
3343
2010-2016
PHRI
Back To Top